In an adult patient with a symptomatic large or recurrent pneumothorax, what is the best management: conservative treatment with 100% FiO₂, needle aspiration, chest tube placement, or chest tube placement with pleurodesis?

Chest Tube Placement (Option C)

For a symptomatic large or recurrent pneumothorax in adults, chest tube placement is the recommended initial management approach, with pleurodesis reserved for recurrence prevention rather than routine first-line use.

Initial Management Algorithm

The choice among your options depends critically on pneumothorax type (primary vs secondary) and clinical presentation:

For Primary Spontaneous Pneumothorax (PSP)

Needle aspiration (option b) is actually preferred over chest tube for initial treatment of symptomatic PSP 1. The 2023 BTS guidelines show that needle aspiration results in:

• Shorter hospital stays compared to chest tube drainage 1
• Equivalent efficacy to chest tubes 2
• Superior safety profile with fewer complications 2

However, chest tube placement becomes necessary when:

• Needle aspiration fails (unsuccessful re-expansion)
• Patient has high-risk features
• Persistent air leak develops
• Patient is hemodynamically unstable

For Secondary Spontaneous Pneumothorax (SSP)

Chest tube drainage is more appropriate for SSP patients (those >50 years, smokers, or with underlying lung disease) 1. These patients tolerate pneumothorax poorly and require more aggressive initial management.

Why NOT the Other Options?

Conservative Management with 100% FiO₂ (Option A)

• Only appropriate for small, minimally symptomatic pneumothoraces 1
• Your question specifies "symptomatic large or recurrent" - this excludes conservative management
• While 100% oxygen increases pleural air reabsorption rates, it's insufficient as sole therapy for large symptomatic pneumothoraces

Chest Tube + Pleurodesis (Option D)

This is NOT recommended as first-line treatment 3, 1. The evidence is clear:

• Chemical pleurodesis should only be attempted if the patient is unwilling or unable to undergo surgery 3
• Pleurodesis is reserved for recurrent pneumothorax, not first presentation 1
• Surgical pleurodesis (VATS) has far lower recurrence rates than chemical pleurodesis 3
• Chemical pleurodesis causes significantly more pain requiring opioid analgesia 1
• Tetracycline pleurodesis may increase post-treatment mortality 1

Practical Management Pathway

For symptomatic large pneumothorax:

1. First-line: Needle aspiration (if PSP) or small-bore chest tube (<14F) 2, 4

2. If aspiration fails or SSP: Insert chest tube with underwater seal

3. Apply suction only after 48 hours if slow to re-expand 3

   • Use high-volume, low-pressure systems (-10 to -20 cm H₂O)
   • Avoid early suction to prevent re-expansion pulmonary edema 3

4. Surgical referral timing:

   • At 3-5 days for persistent air leak or failure to re-expand 3
   • Earlier (2-4 days) if underlying lung disease, large persistent leak, or failed re-expansion 3

For recurrent pneumothorax:

• Surgical intervention (VATS with pleurodesis) is preferred over chemical pleurodesis 3
• Chemical pleurodesis only if patient refuses or cannot tolerate surgery 3, 1

Critical Pitfalls to Avoid

• Don't apply suction immediately - wait 48 hours to avoid re-expansion pulmonary edema 3
• Don't use chemical pleurodesis at first presentation - it has higher recurrence rates and more complications than surgery 3, 1
• Don't use large-bore chest tubes (≥14F) routinely - they cause more complications than needle aspiration or small-bore tubes 2
• Don't delay surgical referral beyond 5-7 days for persistent air leak 3

Answer Summary

The best single answer from your options is (c) chest tube, but with important caveats: needle aspiration should be attempted first for PSP, and pleurodesis should NOT be added routinely at first presentation. Pleurodesis (option d) is reserved for recurrent pneumothorax or patients who refuse surgery.